Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis
November 6th, 2019
We describe an imaging approach for the determination of the average oligomeric state of mEGFP-tagged-receptor oligomers induced by ligand binding in the plasma membrane of living cells. The protocol is based on Total Internal Reflection Fluorescence (TIRF) microscopy combined with Number and Brightness (N&B) analysis.
Overview
This study presents an innovative imaging technique to assess the oligomeric state of mEGFP-tagged receptor oligomers on the plasma membrane of living cells, particularly in response to ligand binding. Using Total Internal Reflection Fluorescence (TIRF) microscopy alongside Number and Brightness (N&B) analysis, the researchers can explore receptor dynamics in real time.
Key Study Components
Research Area
- Cell biology
- Microscopy
- Molecular biology
Background
- Receptor clustering is critical for signaling pathways.
- Measuring receptor clustering has been challenging due to limited methods.
- TIRF microscopy provides fast imaging capabilities near the cell surface.
Methods Used
- Total Internal Reflection Fluorescence (TIRF) microscopy
- HeLa cells
- Number and Brightness (N&B) analysis
Main Results
- The protocol successfully tracks diffusion of FGFR1-mEGFP molecules.
- Average oligomeric states were determined post-ligand binding.
- This method facilitates real-time observation of receptor dynamics.
Conclusions
- The study offers a reliable approach to connect spatial and temporal organization of receptors.
- This method has broad applications for studying protein clustering and signaling in live cells.
Frequently Asked Questions
Executive Industry Relevance
Quantifying receptor oligomerization dynamics at the cell surface is critical for de-risking early target validation and understanding mechanistic drivers of signaling. The integration of TIRF microscopy with Number and Brightness (N&B) analysis enables real-time, quantitative assessment of receptor clustering in live cells, supporting predictive confidence in pathway interrogation. This capability informs portfolio triage and prioritization by providing direct evidence of ligand-induced receptor organization and kinetics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct measurement of receptor clustering events in live-cell contexts.
- Supports mechanistic de-risking by quantifying ligand-induced oligomerization kinetics.
- Provides functional validation of target engagement at the membrane interface.
- Facilitates predictive confidence in pathway modulation strategies.
Screening & Assay Development
- Delivers quantitative, reproducible readouts of oligomeric state for assay standardization.
- Enables high-content analysis across large cell areas and subcellular compartments.
- Supports rapid acquisition suitable for kinetic screening of receptor modulators.
- Prepares validated systems for downstream compound evaluation workflows.
Translational & Preclinical Research
- Aligns receptor clustering dynamics with disease-relevant signaling mechanisms.
- Provides continuity from discovery-stage mechanistic insights to preclinical validation.
- Enables risk-adjusted advancement decisions based on real-time receptor behavior.
- Supports translational biomarker development when clustering correlates with functional outcomes.
Pipeline & Workflow Integration
This method bridges early discovery and lead identification by enabling quantitative, live-cell analysis of receptor oligomerization in response to ligands or candidate therapeutics.
- Discovery Biology: Supports hypothesis testing on receptor clustering and pathway activation.
- Screening: Provides assay-ready, quantitative outputs for compound evaluation.
- Analytics: Generates statistical measurements of brightness and oligomeric state for condition comparison.
- Translational Research: Connects mechanistic clustering events to preclinical models when supported by downstream data.
- Enterprise Reuse: Offers a scalable, adaptable platform for diverse receptor and ligand systems.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces ambiguity in target validation.
- Operational Value: Standardizes live-cell clustering assays with high reproducibility and scalability.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency by clarifying mechanistic risk.
- Portfolio Impact: Enables risk-adjusted prioritization based on quantitative receptor dynamics.
Implementation Considerations
- Requires expertise in fluorescence fluctuation analysis and live-cell imaging.
- Needs access to TIRF microscopy with fast acquisition and environmental control.
- Demands rigorous standardization of controls for monomeric and dimeric reference states.
- Adaptable to various receptor systems with appropriate fluorescent labeling.
- Limited to average oligomeric state estimation; cannot resolve all mixture fractions.
Biopharma FAQs
Chapters in this video
0:04
Title
1:48
Sample Preparation
2:38
TIRF Imaging: Alignment of the Laser Line and Optimization of TIRF Illumination
4:05
TIRF Imaging: Capture of the Time Series
5:46
Number & Brightness (N&B): Quality Check of the Time Series
6:34
Number & Brightness (N&B): Computation of the B-values in Selected Region-of-interest (ROI)
8:19
Results: N&B Analysis and Kinetics of FGFR1 Oligomerization
9:42
Conclusion
